From Latent Manifolds to Functional Probes: An Interpretable, Kinome-Scale Generative Machine Learning Framework for Family-Targeted Kinase Inhibitor Design
Kassab, R.; Krishnan, K.; Verkhivker, G.
Show abstract
The design of selective kinase inhibitors remains a formidable challenge due to the high structural conservation of the ATP-binding site across the kinome. While modern generative AI has enabled rapid exploration of chemical space, many advanced models operate as black boxes, obscuring the chemical rationale behind design choices and limiting interpretability. To explore these bottlenecks, we present a modular, generative framework for de novo design of SRC kinase inhibitors, integrating ChemVAE-based latent space modeling, a chemically interpretable Kinase Inhibition Likelihood (KIL) scoring function, Bayesian optimization, and cluster-guided local neighborhood sampling. The results demonstrate that kinase inhibitors spontaneously organize into a coherent, low-dimensional manifold in latent space, with SRC acting as a structural "hub" that enables rational scaffold transformation. Our local neighborhood sampling-based approach successfully converts inhibitors from other kinase families (notably LCK) into novel SRC-like chemotypes, with LCK-derived molecules accounting for [~]40% of high-similarity outputs. Critically, we expose a fundamental representation gap: despite aromatic ring count being a top KIL feature, SMILES-based generation systematically fails to access multi-ring pharmacophores characteristic of clinical kinase inhibitors. This limitation cannot be overcome by scoring refinement alone, demanding topology-aware representations. Our framework also demonstrates that unbiased exploration paired with cluster-guided sampling outperforms active-biased optimization, which traps search in narrow local optima. By exposing representational gaps and showcasing scaffold-aware navigation of latent space, this study argues for hybrid systems that combine the diagnostic transparency of interpretable machine learning frameworks with the generative power of modern architectures.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Rational Discovery of Dual-Action Multi-Target Kinase Inhibitor for Precision Anti-Cancer Therapy Using Structural Systems Pharmacology 95%
- AI-Assisted Chemical Probe Discovery for the Understudied Calcium-Calmodulin Dependent Kinase, PNCK 94%
- Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with Deep Graph Networks 94%
Similar papers in this journal
- EVOSYNTH: Enabling Multi-Target Drug Discovery through Latent Evolutionary Optimization and Synthesis-Aware Prioritization 97%
- Using macromolecular electron densities to improve the enrichment of active compounds in virtual screening 94%
- Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators 92%
Similar papers in this journal
- Merging Bioactivity Predictions from Cell Morphology and Chemical Fingerprint Models Using Similarity to Training Data 96%
- DrugDiff - small molecule diffusion model with flexible guidance towards molecular properties 96%
- Comprehensive machine learning boosts structure-based virtual screening for PARP1 inhibitors 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.